Evidence map›Paper›PMID 37009541›Full record

ReviewJournal of vitreoretinal diseases

Clinical Practice Update: Management of Infectious Endophthalmitis After Intravitreal Anti-VEGF Injection.

Rohan Merani, Mark W Johnson, Colin A McCannel, Harry W Flynn, Ingrid U Scott, Alex P Hunyor

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Journal of vitreoretinal diseases. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Intraocular inflammation following intravitreal injections of anti-vascular endothelial growth factor drugs.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2025
    Observational
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Rohan MeraniConcord Repatriation General Hospital, Sydney, NSW, Australia.
Mark W JohnsonDepartment of Ophthalmology and Visual Sciences, Kellogg Eye Center, University of Michigan, Ann Arbor, MI, USA.
Colin A McCannelUCLA Stein Eye Institute; Department of Ophthalmology, David Geffen School of Medicine at UCLA, University of California, Los Angeles, CA, USA.
Harry W FlynnDepartment of Ophthalmology, Bascom Palmer Eye Institute, Miami, FL, USA.ORCID https://orcid.org/0000-0002-9990-7467
Ingrid U ScottDepartments of Ophthalmology and Public Health Sciences, Penn State College of Medicine, Hershey, Philadelphia, PA, USA.
Alex P HunyorSave Sight Institute, Specialty of Clinical Ophthalmology and Eye Health, Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia.ORCID https://orcid.org/0000-0002-8182-6167

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Although infectious endophthalmitis after intravitreal antivascular endothelial growth factor injections is rare, it is the most feared and potentially devastating complication of this procedure. There is no high-level evidence to provide definitive guidance on the management of endophthalmitis occurring after intravitreal injection (IVI). This clinical practice update reviews the published literature regarding post-IVI endophthalmitis and highlights areas in which further research is needed to better guide its management.

Indexed as

endophthalmitisintravitreal injectionvascular endothelial growth factor

Identifiers

PMID37009541
PMCPMC9954776

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.